AU2002310922A1 - Interferons in the treatment of ischemia - Google Patents
Interferons in the treatment of ischemiaInfo
- Publication number
- AU2002310922A1 AU2002310922A1 AU2002310922A AU2002310922A AU2002310922A1 AU 2002310922 A1 AU2002310922 A1 AU 2002310922A1 AU 2002310922 A AU2002310922 A AU 2002310922A AU 2002310922 A AU2002310922 A AU 2002310922A AU 2002310922 A1 AU2002310922 A1 AU 2002310922A1
- Authority
- AU
- Australia
- Prior art keywords
- interferons
- ischemia
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0111070.9 | 2001-05-04 | ||
GB0111070A GB0111070D0 (en) | 2001-05-04 | 2001-05-04 | Treatment of cerebral ischemia |
GB0118023A GB0118023D0 (en) | 2001-07-24 | 2001-07-24 | Treatment of ischemia |
GB0118023.1 | 2001-07-24 | ||
PCT/EP2002/003758 WO2002089828A2 (en) | 2001-05-04 | 2002-04-04 | Interferons in the treatment of ischemia |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002310922A1 true AU2002310922A1 (en) | 2002-11-18 |
Family
ID=26246039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002310922A Abandoned AU2002310922A1 (en) | 2001-05-04 | 2002-04-04 | Interferons in the treatment of ischemia |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002310922A1 (en) |
WO (1) | WO2002089828A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2477577A1 (en) * | 2002-03-12 | 2003-09-18 | Maxygen Aps | Interferon beta-like molecules for treatment of stroke |
EP1608400B1 (en) | 2003-03-28 | 2010-06-23 | Faron Pharmaceuticals OY | Elevation of adenosine level by cytokine-induced expression of cd73 |
US7348004B2 (en) | 2003-05-06 | 2008-03-25 | Syntonix Pharmaceuticals, Inc. | Immunoglobulin chimeric monomer-dimer hybrids |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
EP3552627A1 (en) | 2003-05-06 | 2019-10-16 | Bioverativ Therapeutics Inc. | Clotting factor-fc chimeric proteins to treat hemophilia |
FI20051003A0 (en) * | 2005-10-07 | 2005-10-07 | Faron Pharmaceuticals Oy | A method of treating or preventing an ischemic reperfusion injury or multiple organ disorder |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE462364B (en) * | 1988-09-30 | 1990-06-18 | Goeran Hansson | USING GAMMA INTERFERON FOR PREPARING A PREPARATION FOR TREATMENT OF VASCULAR STENOS |
US5370870A (en) * | 1989-10-06 | 1994-12-06 | Genentech, Inc. | Method for protection against reactive oxygen species |
GB9506051D0 (en) * | 1995-03-24 | 1995-05-10 | Univ Singapore | Gene expression |
WO1997018831A1 (en) * | 1995-11-17 | 1997-05-29 | Toray Industries, Inc. | Endothelial cell protective |
JPH09151137A (en) * | 1995-12-01 | 1997-06-10 | Toray Ind Inc | Medicine for inhibiting multiplication of smooth muscle cell |
ES2314786T3 (en) * | 1998-04-02 | 2009-03-16 | Genentech, Inc. | USE OF INTERFERON GAMMA FOR THE TREATMENT OF CARDIAC HYPERTROPHY. |
-
2002
- 2002-04-04 WO PCT/EP2002/003758 patent/WO2002089828A2/en not_active Application Discontinuation
- 2002-04-04 AU AU2002310922A patent/AU2002310922A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002089828A2 (en) | 2002-11-14 |
WO2002089828A3 (en) | 2003-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1370249A4 (en) | Novel dendriticpolymers and their biomedical uses | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
AU2001234837A1 (en) | Azapeptides useful in the treatment of hepatitis c | |
AU2003212634A1 (en) | Compounds useful in the treatment of cancer | |
AU2001260834A1 (en) | The treatment of herpes | |
AU2002319286A1 (en) | Skin treatment | |
GB2376928B (en) | Personal hoverplane having four tiltmotors | |
AU2002310922A1 (en) | Interferons in the treatment of ischemia | |
AU2003220026A1 (en) | Methods and compositions for the treatment of ischemia | |
AU2002312373A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2003293500A1 (en) | Lactoferrin in the reduction of pain | |
AU2002366195A1 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
AU2001258675A1 (en) | Treating infections | |
AU2002241162A1 (en) | Intimins in the prevention or treatment of infections:ii | |
AU2002365256A1 (en) | Gemcitabine in the treatment of smallpox | |
AU2002316943A1 (en) | Hair treatment composition | |
AU2002343516A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002320621A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002229979A1 (en) | Polymorphisms in the human cmoat gene and uses thereof | |
AU2002357468A1 (en) | Use of 2-acylindoles in the treatment of tumors | |
AU2002304728A1 (en) | Enzymes combination coadjuvating in the interferon therapy | |
AU2002310606A1 (en) | Surface treatment | |
AUPR589401A0 (en) | Particle treatment | |
AUPR278101A0 (en) | Personal object | |
AU2002308074A1 (en) | Skin treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |